Atrial fibrillation is amenable to anticoagulation with heparin medications, but its use is somewhat limited because it requires subcutaneous injection for use.
Atrial fibrillation is one of the most common cardiac arrhythmias, a small fluttering of the atria that occurs when the contraction and diastole of the heart loses its normal rhythm. Anticoagulation is a very important part of the treatment of atrial fibrillation, preventing the formation of blood clots in the atria and reducing the risk of stroke.
There are three types of anticoagulant drugs: heparin, including normal heparin and low molecular heparin, which is injected subcutaneously into the patient’s body to achieve anticoagulant effect, and is usually used during the patient’s hospitalization; warfarin, which requires regular blood sampling and testing of the International Normalized Ratio (INR) to monitor the effect of anticoagulation; and newer oral anticoagulant drugs, such as rivaroxaban, dabigatran, and so on.
For patients with atrial fibrillation, the need for anticoagulation and the use of what kind of drugs for anticoagulation therapy need to be carried out under the guidance of a doctor.